A 17-year-old male was referred to the emergency room with sharp abdominal pain, pallor, sweating, and vomiting 12 h after the administration of his first Pfizer-BioNTech vaccine for coronavirus disease 2019 (COVID-19). He had abdominal pain, an increase in serum lipase value of > 3 times the upper limits of normal, and magnetic resonance imaging (MRI) findings consistent with acute mild pancreatitis (AP). He was started on treatment with fluid therapy and non-steroidal anti-inflammatory drugs for pain management, after which he recovered rapidly and was discharged on the fourth day after hospitalization. The available data are difficult to interpret as AP is a relatively frequent disease, but its occurrence after vaccination seems extremely rare. Although it is a rare event, AP should be considered after COVID-19 vaccination, especially in those exhibiting abdominal tenderness and vomiting, which should be promptly treated and adequately investigated.
【저자키워드】 COVID-19, Vaccine, Pancreatitis, 【초록키워드】 Treatment, coronavirus disease, vaccination, therapy, Hospitalization, magnetic resonance imaging, abdominal pain, MRI, serum, COVID-19 vaccination, management, male, Pain, Mild, disease, Pfizer-BioNTech, administration, non-steroidal anti-inflammatory drug, available data, vomiting, limit, sweating, Occurrence, investigated, treated, increase in, discharged, exhibiting, pallor, 【제목키워드】 mRNA, Adolescent,